XML 83 R38.htm IDEA: XBRL DOCUMENT v3.20.1
BUSINESS DEVELOPMENT - Asset Acquisition, Narrative (Details)
3 Months Ended 12 Months Ended
Sep. 09, 2019
USD ($)
asset
Jan. 04, 2019
USD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Schedule Of Asset Acquisition [Line Items]          
Research and development     $ 20,816,000 $ 18,321,000  
Rebound          
Schedule Of Asset Acquisition [Line Items]          
Upfront payment $ 67,100,000        
Contingent development milestone payments commitment (up to) $ 35,000,000.0        
Number of assets acquired | asset 1        
Remaining net assets acquired $ 7,200,000        
Development milestone         $ 5,000,000.0
In-process research and development         $ 5,000,000.0
Research and development       $ 1,700,000  
Rebound | Cash and Cash Equivalents          
Schedule Of Asset Acquisition [Line Items]          
Remaining net assets acquired 2,100,000        
Rebound | Deferred Tax Asset          
Schedule Of Asset Acquisition [Line Items]          
Remaining net assets acquired 4,200,000        
Rebound | In-Process Research and Development Expense          
Schedule Of Asset Acquisition [Line Items]          
Upfront payment $ 59,900,000        
ISC | Enabling technology license          
Schedule Of Asset Acquisition [Line Items]          
Upfront payment, intangible assets   $ 1,700,000      
Option to acquire, period subsequent to first commercial sale   4 years      
Maximum future purchase price, if circumstances met (not to exceed)   $ 80,000,000.0